Free Trial

Aurinia Pharmaceuticals (AUPH) Stock Forecast & Price Target

$5.57
-0.09 (-1.59%)
(As of 06/25/2024 ET)

Aurinia Pharmaceuticals - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Consensus Price Target

$10.00
79.53% Upside
High Forecast$13.00
Average Forecast$10.00
Low Forecast$8.00
TypeCurrent Forecast
6/26/23 to 6/25/24
1 Month Ago
5/27/23 to 5/26/24
3 Months Ago
3/28/23 to 3/27/24
1 Year Ago
6/26/22 to 6/26/23
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
3 Buy rating(s)
3 Buy rating(s)
3 Buy rating(s)
3 Buy rating(s)
Hold
1 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$10.00$10.00$10.00$13.00
Forecasted Upside79.53% Upside69.42% Upside69.42% Upside78.47% Upside
Get Aurinia Pharmaceuticals Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for AUPH and its competitors with MarketBeat's FREE daily newsletter.

AUPH Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

AUPH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Aurinia Pharmaceuticals Stock vs. The Competition

TypeAurinia PharmaceuticalsMedical CompaniesS&P 500
Consensus Rating Score
2.75
2.70
2.50
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside79.53% Upside995.75% Upside11.33% Upside
News Sentiment RatingNeutral News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
3/1/2024HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$13.00+122.98%
2/23/2024Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight ➝ Overweight$12.00 ➝ $10.00+65.84%
2/16/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetHold$9.50 ➝ $9.00+55.71%
2/16/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform ➝ Outperform$13.00 ➝ $8.00+34.00%
11/4/2022SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform$17.00 ➝ $12.00+131.66%
11/4/2022Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Market Perform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 07:01 PM ET.

AUPH Forecast - Frequently Asked Questions

What is Aurinia Pharmaceuticals's stock forecast and purchase recommendation?

According to the research reports of 4 Wall Street equities research analysts, the average twelve-month stock price forecast for Aurinia Pharmaceuticals is $10.00, with a high forecast of $13.00 and a low forecast of $8.00. The consensus rating for Aurinia Pharmaceuticals stock is Moderate Buy based on the current 1 hold rating and 3 buy ratings for AUPH. Learn more on AUPH's analyst rating history.

Do Wall Street analysts like Aurinia Pharmaceuticals more than its competitors?

Analysts like Aurinia Pharmaceuticals more than other "medical" companies. The consensus rating score for Aurinia Pharmaceuticals is 2.75 while the average consensus rating score for "medical" companies is 2.70. Learn more on how AUPH compares to other companies.

Does Aurinia Pharmaceuticals's stock price have much upside?

According to analysts, Aurinia Pharmaceuticals's stock has a predicted upside of 69.42% based on their 12-month stock forecasts.


Stock Forecasts and Research Tools

This page (NASDAQ:AUPH) was last updated on 6/25/2024 by MarketBeat.com Staff

From Our Partners